Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment

Published:2024-09-14 Issue: Volume: Page:
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Miller Carly D.¹^ORCID,Likasitwatanakul Pornlada¹²,Toye Eamon¹³,Hwang Justin H.¹,Antonarakis Emmanuel S.¹

Affiliation:

1. Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN

2. Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

3. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2024.2405103

Reference181 articles.

1. Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review;Bergengren O;Eur Urol,2022

2. Role of Androgen Receptor in Prostate Cancer: A Review

3. Current therapy and drug resistance in metastatic castration-resistant prostate cancer

4. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study;Scher HI;Lancet,2010

5. Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP